(0.38%) 5 119.23 points
(0.37%) 38 381 points
(0.49%) 16 007 points
(-1.43%) $82.65
(4.52%) $2.01
(0.46%) $2 357.90
(0.39%) $27.64
(4.57%) $964.25
(-0.26%) $0.932
(-0.40%) $10.98
(-0.57%) $0.796
(1.68%) $93.42
Live Chart Being Loaded With Signals
Venture Life Group plc develops and commercializes oral care products, food supplements, medical devices, dermo-cosmetics, and topical products for the ageing population in the United Kingdom, the Netherlands, China, Germany, Italy, Switzerland, rest of Europe, and internationally...
Stats | |
---|---|
आज की मात्रा | 216 849 |
औसत मात्रा | 215 038 |
बाजार मूल्य | 51.23M |
EPS | £0 ( 2024-04-11 ) |
Last Dividend | £0.0400 ( 2018-05-24 ) |
Next Dividend | £0 ( N/A ) |
P/E | 40.50 |
ATR14 | £0.452 (1.11%) |
Venture Life Group PLC सहसंबंध
10 सबसे अधिक सकारात्मक सहसंबंध |
---|
10 सबसे अधिक नकारात्मक सहसंबंध |
---|
क्या आप जानते हैं?
कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।
कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।
Venture Life Group PLC वित्तीय
Annual | 2023 |
राजस्व: | £51.41M |
सकल लाभ: | £13.51M (26.27 %) |
EPS: | £0.00730 |
FY | 2023 |
राजस्व: | £51.41M |
सकल लाभ: | £13.51M (26.27 %) |
EPS: | £0.00730 |
FY | 2022 |
राजस्व: | £43.98M |
सकल लाभ: | £17.67M (40.17 %) |
EPS: | £0.00410 |
FY | 2021 |
राजस्व: | £32.76M |
सकल लाभ: | £12.96M (39.55 %) |
EPS: | £0.0278 |
Financial Reports:
No articles found.
Venture Life Group PLC Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
First Dividend | £0.0400 | 2014-06-11 |
Last Dividend | £0.0400 | 2018-05-24 |
Next Dividend | £0 | N/A |
Payout Date | 2018-06-22 | |
Next Payout Date | N/A | |
# dividends | 5 | -- |
Total Paid Out | £0.200 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.4 | -- |
Div. Sustainability Score | 8.11 | |
Div.Growth Potential Score | 4.20 | |
Div. Directional Score | 6.15 | -- |
Year | Amount | Yield |
---|---|---|
2014 | £0 | 0.00% |
2015 | £0 | 0.00% |
2016 | £0 | 0.00% |
2017 | £0 | 0.00% |
2018 | £0.0400 | 0.10% |
2019 | £0 | 0.00% |
2020 | £0 | 0.00% |
2021 | £0 | 0.00% |
2022 | £0 | 0.00% |
2023 | £0 | 0.00% |
2024 | £0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
SUPR.L | Dividend Knight | 2023-07-13 | Quarterly | 8 | 3.25% | |
KEYS.L | Dividend Knight | 2023-09-21 | Annually | 7 | 2.29% | |
CCJI.L | Dividend Knight | 2023-07-06 | Semi-Annually | 9 | 2.14% | |
QXT.L | Ex Dividend Junior | 2023-07-27 | Sporadic | 11 | 0.46% | |
GHH.L | Dividend Knight | 2023-06-22 | Annually | 27 | 0.91% | |
AMC.L | Dividend Knight | 2023-06-01 | Insufficient data to determine frequency | 2 | 55.57% | |
TPFG.L | Dividend Knight | 2023-09-21 | Annually | 11 | 3.16% | |
MACF.L | Dividend King | 2023-09-14 | Semi-Annually | 32 | 1.94% | |
CREI.L | Dividend Knight | 2023-07-20 | Quarterly | 11 | 3.34% | |
RUR.L | Dividend Knight | 2023-06-22 | Sporadic | 20 | 10.67% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0179 | 1.500 | 9.64 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.00771 | 1.200 | 9.74 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0123 | 1.500 | -0.975 | -1.462 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.084 | 0.800 | 9.58 | 7.67 | [1 - 3] |
quickRatioTTM | 0.735 | 0.800 | -0.380 | -0.304 | [0.8 - 2.5] |
cashRatioTTM | 0.189 | 1.500 | -0.0587 | -0.0880 | [0.2 - 2] |
debtRatioTTM | 0.204 | -1.500 | 6.60 | -9.90 | [0 - 0.6] |
interestCoverageTTM | 3.00 | 1.000 | -0.00174 | -0.00174 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.0540 | 2.00 | 9.98 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.0350 | 2.00 | 9.98 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.320 | -1.500 | 8.72 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.263 | 1.000 | 8.95 | 8.95 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0865 | 1.000 | -0.271 | -0.271 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.280 | 1.000 | 9.56 | 9.56 | [0.2 - 2] |
assetTurnoverTTM | 0.430 | 0.800 | -0.465 | -0.372 | [0.5 - 2] |
Total Score | 8.11 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 57.00 | 1.000 | 4.34 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0123 | 2.50 | -0.627 | -1.462 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.0350 | 2.00 | 9.99 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.0540 | 2.00 | 9.98 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 77.45 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.133 | 1.000 | 9.18 | 0 | [0.1 - 0.5] |
Total Score | 4.20 |
Venture Life Group PLC
Venture Life Group plc develops and commercializes oral care products, food supplements, medical devices, dermo-cosmetics, and topical products for the ageing population in the United Kingdom, the Netherlands, China, Germany, Italy, Switzerland, rest of Europe, and internationally. It operates through Venture Life Brands and Customer Brands segments. The company offers neurology products, including NeuroAge, NeuroAge Sleep, and NeuroAge NRG food supplements to enhance alertness, cognitive function, and mental performance in healthy brain; and Original Bioscalin to treat and prevent hair loss, hair thinning, and baldness. It also provides Fungal Nail Solution, which helps to treat and prevent fungal infections; and Fungal Nail Cleanser for the hygiene of hands and feet prone to fungal nail infections under the Myco Clear brand name. In addition, the company offers UltraDEX product for bad breath; Dently Dual Action, a mouthwash, which lifts and removes plaque and bacteria from the teeth and gums; and Procto-eze plus for anal irritation, including haemorrhoids condition. Further, it provides women healthcare products comprising vonalei bacterial vaginosis, a refreshing gel; vonalei Vaginal Atrophy, a vaginal cream; vonalei candidiasis, a soothing cream-gel for thrush; and vonalei intimate cleansing foam. Additionally, it offers Cleansing Foam, Cleansing Cream, and Serum under the Rosa calma brand name; and skincare ranges to hydrate, nourish, and recondition the skin, as well as to prevent the lines and wrinkles under the Lubatti Classic and the Lubatti Anti-age brand names. The company sells its products through a network of international partners, retail pharmacies, as well as grocery multiple retailers. Venture Life Group plc was incorporated in 2005 and is headquartered in Bracknell, the United Kingdom.
के बारे में लाइव सिग्नल्स
इस पृष्ठ पर प्रस्तुत लाइव सिग्नल्स NA को कब खरीदना या बेचना है, इसका निर्धारण करने में मदद करते हैं। सिग्नल्स में 1-मिनट की देरी हो सकती है; सभी बाजार सिग्नल्स की तरह, त्रुटि या गलतियों की संभावना होती है।
लाइव ट्रेडिंग सिग्नल्स स्थायी नहीं हैं, और getagraph.com इन सिग्नल्स पर किए गए किसी भी कार्रवाई के लिए जिम्मेदारी नहीं रखते हैं, जैसा कि उपयोग की शर्तें में वर्णित है। सिग्नल्स एक व्यापक श्रृंखला के तकनीकी विश्लेषण संकेतकों पर आधारित हैं